We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 46

Follow-on biologics in Canada: a look at the new draft guidelines
  • Torys LLP
  • Canada
  • May 27 2008

Health Canada has released a draft guidance document entitled “Information and Submission Requirements for Subsequent Entry Biologics (SEBs).”


Ontario court confirms generic drug manufacturers not entitled to unjust enrichment
  • Torys LLP
  • Canada
  • January 22 2013

On January 15, 2013, the Ontario Superior Court of Justice (Ontario Court) granted a motion for partial summary judgment in Apotex Inc. v. Abbott


Canada's approach to functional foods
  • Torys LLP
  • Canada
  • April 21 2010

Today’s diet- and health-conscious environment has led to a proliferation of functional food marketing claims that advertise the specific health-enhancing characteristics of a food product


Health Canada to list authorized clinical trials online
  • Torys LLP
  • Canada
  • October 25 2012

On October 18, 2012, Health Canada issued a news release and subsequent Drugs and Health Products Notice announcing that it will create a web-based list of clinical trials authorized by Health Canada


Ontario case on product liability shows the immense scope of a class action trial
  • Torys LLP
  • Canada
  • July 5 2012

In a highly anticipated decision released on June 26, 2012, the Ontario Superior Court of Justice ruled in favour of the defendants in Andersen v. St. Jude Medical, Inc., Ontario’s first medical product liability class action trial


Ontario government seeks appeal of pharmacies' successful challenge on private label restrictions
  • Torys LLP
  • Canada
  • February 24 2011

The regulation of private label drug products remains in flux with the recent decision of the Ontario Superior Court of Justice (Divisional Court) and potential appeal of that decision


Amendments to the Patented Medicines (Notice of Compliance) Regulations now in force
  • Torys LLP
  • Canada
  • June 13 2008

On June 12, 2008, amendments to the Patented Medicines (Notice of Compliance) Regulations (commonly referred to as the “PM(NOC) Regulations”) came into force


Draft guidelines on subsequent entry biologics
  • Torys LLP
  • Canada
  • February 15 2008

Health Canada has released a draft guidance document titled “Information and Submission Requirements for Subsequent Entry Biologics (SEBs).”


Proposed amendments to the Patented Medicines (Notice of Compliance) Regulations
  • Torys LLP
  • Canada
  • April 29 2008

On April 26, 2008, the government of Canada published for comment proposed amendments to the Patented Medicines (Notice of Compliance) Regulations, commonly referred to as the “PM(NOC) Regulations.”


Canada proposes amending the Food and Drugs Act and creating consumer product safety legislation
  • Torys LLP
  • Canada
  • May 2 2008

On April 8, 2008, the federal government tabled legislation in the House of Commons to amend the Food and Drugs Act and to introduce new consumer product safety legislation in Canada